SCHEMBL30310331

SCHEMBL30310331

N#CC(C[C@@H]1CCNC1=O)NC(=O)CCC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24019848 1.00 — —
SCHEMBL24113375 0.84 CTSS (0.46) —
SCHEMBL25664231 0.81 — —
SCHEMBL24112506 0.80 — —
SCHEMBL23824695 0.80 — —
SCHEMBL23824693 0.80 — —
SCHEMBL24021038 0.80 CTSL (0.49) —
SCHEMBL24582918 0.78 CTSL (0.41) —
SCHEMBL24584319 0.78 CTSL (0.41) —
SCHEMBL24257165 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 — — EP disclosed
Send feedback